While advancements in early detection and treatment have improved survival rates, a significant gap in access to care remains for people with lower incomes or those living in remote areas. Early detection through screening and technological innovation continues to be crucial in reducing mortality rates, as survival rates can exceed 90% when the disease is diagnosed at an early stage.
In recent years, a wave of startups has emerged, leveraging the latest technological advances in areas like artificial intelligence, multi-omics, and personalized medicine to tackle breast cancer from multiple angles. From improving diagnostic tools to changing the way care is delivered, these startups are driving innovation and presenting engaging opportunities for venture capitalists looking to invest in solutions that can make a life-saving difference.
This article spotlights high-impact startups that are providing new early detection of breast cancer and care solutions, offering hope to millions of patients.
RELATED ARTICLE: AI Cancer Care Solutions Changing Prevention and Treatment Strategies — Discover the transformation of oncology care with AI cancer care solutions, improving clinical trials, follow-up care, and disease management.
Gabbi — Eliminating late-stage breast cancer through personal risk assessment
Gabbi is on a mission to eliminate late-stage breast cancer by ensuring every woman understands her personal risk and gains access to early detection. In less than two minutes, Gabbi’s platform assesses a woman’s risk and provides a customized care plan, acting as her virtual breast specialist through telehealth. By identifying those most at risk and delivering the care they need exactly when they need it, Gabbi is transforming the landscape of proactive breast cancer care.Celbrea — Alerting physicians and patients to potential breast pathology
Celbrea is dedicated to supporting the early detection of breast disease worldwide, with a focus on breast cancer. This FDA-cleared Class I medical device offers a painless, easy-to-use solution that alerts physicians and patients to potential breast pathology in just 15 minutes. As breast cancer continues to claim lives every 13 minutes in the US, Celbrea’s mission is clear: empower women to stay on top of monitoring their breast health and improve outcomes through early intervention.Syantra — Early detection of breast cancer with a revolutionary blood test
Vara — Redefining breast cancer screening
Paige.AI — Utilizing AI in cancer treatment
Reimagine Care — Making cancer care more affordable and accessible for everyone
Reimagine Care is transforming the way cancer care is delivered by making it more affordable, accessible, and patient-centric. Founded in 2020, this innovative company partners with healthcare systems and independent oncology practices to support value-based care in community settings. Reimagine Care empowers the scalable delivery of high-quality cancer treatment by offering expert personnel, efficient processes, and an advanced technology platform. This approach ensures exceptional care across various sites, including the comfort of the patient’s home. With a mission to lower costs while enhancing the patient experience, Reimagine Care is leading the shift toward a more sustainable and compassionate oncology care model.RELATED ARTICLE: Innovative Imaging: How AI is Shaping Orthopedics — Explore how AI innovation transforms industries worldwide and enables strategic implementation for success across diverse sectors.
Accelerating progress in early detection of breast cancer and care through strategic investments
Ready to innovate and connect with new healthcare technologies? At Plug and Play, we fast-track innovation in the healthcare industry. Reach out to connect with the most disruptive startups.
